1.27
Health Sciences
Proton therapy lowers risk of side effects in cancer patients
Proton therapy lowers risk of side effects in cancer patients
Proton therapy leads to a significantly lower risk of side effects severe enough to lead to unplanned hospitalizations for cancer patients when compared with traditional radiation. Cure rates between the two groups are almost identical.
Amazing cows hold promise in pioneering sustainable food systems
Amazing cows hold promise in pioneering sustainable food systems
Researchers at Penn Vet are discovering that cows and other livestock found in animal agriculture are critical partners in developing sustainable, regenerative agro-food systems.
A gift for disruption: Visionary Roderick Wong gives back to PennHealthX
A gift for disruption: Visionary Roderick Wong gives back to PennHealthX
Wong, an alum with a medical degree and an MBA, has given Penn Medicine a $6 million gift to endow the Roderick T. Wong PennHealthX Program, one of the largest single gifts to support medical education.
A new era in cystic fibrosis treatment
A new era in cystic fibrosis treatment
FDA approval of new therapies for cystic fibrosis is a major breakthrough for patients, meaning fewer complications, delayed progression and even longer life expectancies.
An Alzheimer’s research pioneer, right here at Penn
An Alzheimer’s research pioneer, right here at Penn
Virginia Man-Yee Lee, a professor and researcher at the Perelman School of Medicine, is the 2020 recipient of a Breakthrough Prize in Life Sciences, earning $3 million for her innovative, inspiring work that could one day cure various neurodegenerative diseases.
Using radiomics to predict breast cancer
Using radiomics to predict breast cancer
Penn researchers can predict 10-year breast cancer recurrence with MRI scans that characterize the genetic makeup of tumors, allowing for individualized, non-invasive treatment.
Promising findings for multiple myeloma immunotherapy
Promising findings for multiple myeloma immunotherapy
Adam Cohen of the Perelman School of Medicine headed a clinical trial that found an experimental therapy can make a difference for patients who have exhausted other options.
Engineering the immune system to tackle glioblastoma
Engineering the immune system to tackle glioblastoma
Immunotherapy is a “game changer” for improving outcomes in treating Glioblastoma Multiforme, the most common, and most lethal, malignant brain tumor in adults.
A new role for a triple-negative breast cancer target
A new role for a triple-negative breast cancer target
A team led by Rumela Chakrabarti of the School of Veterinary Medicine has made new discoveries into how a key protein involved in triple-negative breast cancer functions in puberty.
Uncovering a defective sperm epigenome that leads to male infertility
Uncovering a defective sperm epigenome that leads to male infertility
A new mouse model allows researchers to track defective sperm and potentially find ways to correct it.
In the News
Science
Deciphering a cancer treatment’s dark side
Saar Gill of the Perelman School of Medicine said it would be easier to treat cancer using CAR-T cell therapy without the looming possibility of triggering cytokine release syndrome.
FULL STORY →
The New York Times
Can melatonin vapes safely help people sleep?
Julio Chirinos of the Perelman School of Medicine wrote an editorial to accompany a new study about the effects of marathon running on the heart. “Exercise is great for the entire body, including the arteries,” he said.
FULL STORY →
Rolling Stone
Can melatonin vapes safely help people sleep?
Philip Gehrman of the Perelman School of Medicine commented on the use of melatonin to aid sleep. “There have been quite a few randomized trials showing that melatonin is no better than placebo to help people sleep,” he said.
FULL STORY →
“Academic Minute” (WAMC, Northeast Public Radio)
Jonathan Moreno on bioethics and the transformation of health care in America
PIK Professor Jonathan Moreno discussed the book “Everybody Wants to Go to Heaven but Nobody Wants to Die: Bioethics and the Transformation of Health Care in America,” which he co-authored with President Amy Gutmann.
FULL STORY →
The New York Times
The F.D.A. is in trouble. Here’s how to fix it
Steven Joffe of the Perelman School of Medicine spoke about the tensions between groups that want medical products to be proven effective before the F.D.A. approves them for public use and groups that believe patients can make their own decisions once the products pass basic safety testing. “The F.D.A. has been moving in the latter direction under great political and public pressure,” he said.
FULL STORY →